Report overview
This report contains market size and forecasts of PEGylated Drugs in Global, including the following market information:
Global PEGylated Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global PEGylated Drugs market was valued at 7206.3 million in 2021 and is projected to reach US$ 8691.5 million by 2028, at a CAGR of 2.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Macromolecular Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of PEGylated Drugs include AstraZeneca, Bayer Healthcare, Biogen, BioMarin Pharmaceutical Inc, Coherus BioSciences, Enzon, Horizon Therapeutics, Leadiant Biosciences, Inc. and Merck, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the PEGylated Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global PEGylated Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global PEGylated Drugs Market Segment Percentages, by Type, 2021 (%)
Macromolecular Drugs
Small Molecular Drugs
Nanoparticles
Global PEGylated Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global PEGylated Drugs Market Segment Percentages, by Application, 2021 (%)
Cancer
Hepatitis C
Leukemia
Severe Combined Immunodeficiency Disease
Rheumatoid Arthritis
Crohn Disease
Others
Global PEGylated Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global PEGylated Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies PEGylated Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies PEGylated Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Bayer Healthcare
Biogen
BioMarin Pharmaceutical Inc
Coherus BioSciences
Enzon
Horizon Therapeutics
Leadiant Biosciences, Inc.
Merck
Mylan
Novo Nordisk
Pfizer
Roche
Sandoz
Servier Pharmaceuticals LLC
Takeda Pharmaceutical Company Limited
